{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:45:42Z","timestamp":1787240742177,"version":"build-2736575974"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Postdoctoral Fellowship Program","award":["2020M672502"],"award-info":[{"award-number":["2020M672502"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ50039"],"award-info":[{"award-number":["2022JJ50039"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan Provincial Department of Education, Open Fund for First-Class Disciplines at Hunan University of Chinese Medicine","award":["2021ZYX10"],"award-info":[{"award-number":["2021ZYX10"]}]},{"name":"Yiyang Science and Technology Innovation Plan Project","award":["2024YR28"],"award-info":[{"award-number":["2024YR28"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20917-7","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:58:24Z","timestamp":1761127104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Erdafitinib suppresses pathological retinal angiogenesis via dual targeting of FGFR and VEGFR2 signaling"],"prefix":"10.1038","volume":"15","author":[{"given":"Yingli","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"20917_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuron.2012.06.018","volume":"75","author":"J Ambati","year":"2012","unstructured":"Ambati, J. & Fowler, B. J. Mechanisms of age-related macular degeneration. Neuron 75, 26\u201339 (2012).","journal-title":"Neuron"},{"key":"20917_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/biom13060982","volume":"13","author":"M Choubey","year":"2023","unstructured":"Choubey, M. & Bora, P. Emerging role of Adiponectin\/AdipoRs signaling in choroidal Neovascularization, Age-Related macular Degeneration, and diabetic retinopathy. Biomolecules 13, 982 (2023).","journal-title":"Biomolecules"},{"key":"20917_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00441-021-03514-8","volume":"387","author":"L Tenbrock","year":"2022","unstructured":"Tenbrock, L. et al. Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives. Cell. Tissue Res. 387, 361\u2013375 (2022).","journal-title":"Cell. Tissue Res."},{"key":"20917_CR4","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/ph16081140","volume":"16","author":"A Hang","year":"2023","unstructured":"Hang, A., Feldman, S., Amin, A. P., Ochoa, J. & Park, S. S. Intravitreal Anti-Vascular endothelial growth factor therapies for retinal disorders. Pharmaceuticals (Basel). 16, 1140 (2023).","journal-title":"Pharmaceuticals (Basel)"},{"key":"20917_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.64.5.28","volume":"64","author":"D Sharma","year":"2023","unstructured":"Sharma, D., Zachary, I. & Jia, H. Mechanisms of acquired resistance to Anti-VEGF therapy for neovascular eye diseases. Invest. Ophthalmol. Vis. Sci. 64, 28 (2023).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"20917_CR6","doi-asserted-by":"publisher","first-page":"100421","DOI":"10.1016\/j.xops.2023.100421","volume":"4","author":"CC Wykoff","year":"2024","unstructured":"Wykoff, C. C. et al. Impact of Anti-VEGF treatment and patient characteristics on vision outcomes in neovascular Age-related macular degeneration: up to 6-Year analysis of the AAO IRIS\u00ae registry. Ophthalmol. Sci. 4, 100421 (2024).","journal-title":"Ophthalmol. Sci."},{"key":"20917_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000543352","volume":"68","author":"E Naaman","year":"2025","unstructured":"Naaman, E. et al. Exploring factors behind patient non-adherence to intravitreal anti-VEGF injections in macular diseases. Ophthalmic Res 68, 1\u201317 (2025).","journal-title":"Ophthalmic Res"},{"key":"20917_CR8","doi-asserted-by":"publisher","first-page":"5796","DOI":"10.3390\/cancers13225796","volume":"13","author":"J Szymczyk","year":"2021","unstructured":"Szymczyk, J. et al. FGF\/FGFR-Dependent molecular mechanisms underlying Anti-Cancer drug resistance. Cancers (Basel). 13, 5796 (2021).","journal-title":"Cancers (Basel)"},{"key":"20917_CR9","doi-asserted-by":"publisher","first-page":"e13009","DOI":"10.1111\/cpr.13009","volume":"54","author":"G Liu","year":"2021","unstructured":"Liu, G. et al. Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment. Cell. Prolif. 54, e13009 (2021).","journal-title":"Cell. Prolif."},{"key":"20917_CR10","doi-asserted-by":"publisher","first-page":"175883591989028","DOI":"10.1177\/1758835919890285","volume":"11","author":"C Casadei","year":"2019","unstructured":"Casadei, C. et al. Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors. Ther. Adv. Med. Oncol. 11, 1758835919890285 (2019).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"20917_CR11","doi-asserted-by":"publisher","first-page":"e30836","DOI":"10.1002\/pbc.30836","volume":"71","author":"N Stepien","year":"2024","unstructured":"Stepien, N. et al. Feasibility and antitumour activity of the FGFR inhibitor Erdafitnib in three paediatric CNS tumour patients. Pediatr. Blood Cancer. 71, e30836 (2024).","journal-title":"Pediatr. Blood Cancer"},{"key":"20917_CR12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1080\/17512433.2020.1823830","volume":"13","author":"A D\u2019Angelo","year":"2020","unstructured":"D\u2019Angelo, A., Bagby, S., Galli, I. C., Bortoletti, C. & Roviello, G. Overview of the clinical use of erdafitinib as a treatment option for the metastatic urothelial carcinoma: where do we stand. Expert Rev. Clin. Pharmacol. 13, 1139\u20131146 (2020).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"20917_CR13","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1158\/1535-7163.MCT-16-0518","volume":"16","author":"JD Karkera","year":"2017","unstructured":"Karkera, J. D. et al. Oncogenic characterization and Pharmacologic sensitivity of activating fibroblast growth factor receptor (FGFR) genetic alterations to the selective FGFR inhibitor erdafitinib. Mol. Cancer Ther. 16, 1717\u20131726 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"20917_CR14","first-page":"e4196","volume":"69","author":"A Avdesh","year":"2012","unstructured":"Avdesh, A. et al. Regular care and maintenance of a zebrafish (Danio rerio) laboratory: an introduction.. J. Vis. Exp. 69, e4196 (2012).","journal-title":"J. Vis. Exp."},{"key":"20917_CR15","doi-asserted-by":"crossref","unstructured":"Simms, V. A., Bicknell, R. & Heath, V. L. Development of an ImageJ-based method for analysing the developing zebrafish vasculature. Vascular Cell 9, (2017).","DOI":"10.24238\/13221-9-1-172"},{"key":"20917_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12861-015-0066-9","volume":"15","author":"R Kaufman","year":"2015","unstructured":"Kaufman, R. et al. Development and origins of zebrafish ocular vasculature. BMC Dev. Biol. 15, 18 (2015).","journal-title":"BMC Dev. Biol."},{"key":"20917_CR17","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"KM Connor","year":"2009","unstructured":"Connor, K. M. et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat. Protoc. 4, 1565\u20131573 (2009).","journal-title":"Nat. Protoc."},{"key":"20917_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.3.2.3","volume":"3","author":"JR Hombrebueno","year":"2014","unstructured":"Hombrebueno, J. R., Luo, C., Guo, L., Chen, M. & Xu, H. Intravitreal injection of normal saline induces retinal degeneration in the C57BL\/6J mouse. Transl Vis. Sci. Technol. 3, 3 (2014).","journal-title":"Transl Vis. Sci. Technol."},{"key":"20917_CR19","doi-asserted-by":"publisher","first-page":"e01874","DOI":"10.1128\/AAC.01874-18","volume":"63","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. In vitro antimicrobial activity of diacerein on 76 isolates of Gram-Positive Cocci from bacterial keratitis patients and in vivo study of diacerein eye drops on Staphylococcus aureus keratitis in mice. Antimicrob. Agents Chemother. 63, e01874\u2013e01818 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"20917_CR20","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1523\/JNEUROSCI.3714-07.2008","volume":"28","author":"I Soto","year":"2008","unstructured":"Soto, I. et al. Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J. Neurosci. 28, 548\u2013561 (2008).","journal-title":"J. Neurosci."},{"key":"20917_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jconrel.2015.01.001","volume":"200","author":"VA Huu","year":"2015","unstructured":"Huu, V. A. et al. Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye. J. Control Release. 200, 71\u201377 (2015).","journal-title":"J. Control Release"},{"key":"20917_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41418-022-01046-4","volume":"30","author":"F Yao","year":"2023","unstructured":"Yao, F. et al. Pathologically high intraocular pressure disturbs normal iron homeostasis and leads to retinal ganglion cell ferroptosis in glaucoma. Cell. Death Differ. 30, 69\u201381 (2023).","journal-title":"Cell. Death Differ."},{"key":"20917_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10456-009-9155-3","volume":"12","author":"A Stahl","year":"2009","unstructured":"Stahl, A. et al. Computer-aided quantification of retinal neovascularization. Angiogenesis 12, 297\u2013301 (2009).","journal-title":"Angiogenesis"},{"key":"20917_CR24","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1161\/01.CIR.0000062702.60708.C4","volume":"107","author":"P Secchiero","year":"2003","unstructured":"Secchiero, P. et al. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 107, 2250\u20132256 (2003).","journal-title":"Circulation"},{"key":"20917_CR25","first-page":"1990","volume":"9","author":"JJ Huang","year":"2017","unstructured":"Huang, J. J. et al. Therapeutic ultrasound protects HUVECs from ischemia\/hypoxia-induced apoptosis via the PI3K-Akt pathway. Am. J. Transl Res. 9, 1990\u20131999 (2017).","journal-title":"Am. J. Transl Res."},{"key":"20917_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-017-0620-0","volume":"16","author":"L Liu","year":"2017","unstructured":"Liu, L. et al. MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma. Mol. Cancer. 16, 50 (2017).","journal-title":"Mol. Cancer"},{"key":"20917_CR27","doi-asserted-by":"crossref","unstructured":"Gentile, M. T., Pastorino, O. & Bifulco, M. & Colucci-D\u2019Amato, L. HUVEC Tube-formation Assay to Evaluate the Impact of Natural Products on Angiogenesis. J. Vis. Exp. (2019).","DOI":"10.3791\/58591"},{"key":"20917_CR28","doi-asserted-by":"publisher","first-page":"C426","DOI":"10.1152\/ajpcell.00400.2014","volume":"308","author":"AA McDonough","year":"2015","unstructured":"McDonough, A. A., Veiras, L. C., Minas, J. N. & Ralph, D. L. Considerations when quantitating protein abundance by Immunoblot. Am. J. Physiol. Cell. Physiol. 308, C426\u2013433 (2015).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"20917_CR29","doi-asserted-by":"crossref","unstructured":"Graham, M. H. & Edwards, M. S. Statistical significance versus fit: estimating the importance of individual factors in ecological analysis of variance. Oikos (2001).","DOI":"10.1034\/j.1600-0706.2001.930317.x"},{"key":"20917_CR30","unstructured":"Hanusz, Z., Tarasinska, J. & Zielinski, W. Shapiro\u2013Wilk test with known mean. (2016)."},{"key":"20917_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.eururo.2023.05.037","volume":"85","author":"CS Groeneveld","year":"2024","unstructured":"Groeneveld, C. S. et al. Proteogenomic characterization of bladder cancer reveals sensitivity to apoptosis induced by tumor necrosis Factor-related apoptosis-inducing ligand in FGFR3-mutated tumors. Eur. Urol. 85, 483\u2013494 (2024).","journal-title":"Eur. Urol."},{"key":"20917_CR32","doi-asserted-by":"publisher","first-page":"e169241","DOI":"10.1172\/JCI169241","volume":"134","author":"A Okato","year":"2024","unstructured":"Okato, A. et al. FGFR Inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression. J. Clin. Invest. 134, e169241 (2024).","journal-title":"J. Clin. Invest."},{"key":"20917_CR33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/ncb3574","volume":"19","author":"SS Hasan","year":"2017","unstructured":"Hasan, S. S. et al. Endothelial Notch signalling limits angiogenesis via control of artery formation. Nat. Cell. Biol. 19, 928\u2013940 (2017).","journal-title":"Nat. Cell. Biol."},{"key":"20917_CR34","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1161\/CIRCULATIONAHA.118.033939","volume":"138","author":"S Meng","year":"2018","unstructured":"Meng, S. et al. TBX20 regulates angiogenesis through the prokineticin 2-Prokineticin receptor 1 pathway. Circulation 138, 913\u2013928 (2018).","journal-title":"Circulation"},{"key":"20917_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10456-018-9613-x","volume":"21","author":"P Nowak-Sliwinska","year":"2018","unstructured":"Nowak-Sliwinska, P. et al. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis 21, 425\u2013532 (2018).","journal-title":"Angiogenesis"},{"key":"20917_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10456-020-09761-7","volume":"24","author":"LJ Greenspan","year":"2021","unstructured":"Greenspan, L. J. & Weinstein, B. M. To be or not to be: endothelial cell plasticity in development, repair, and disease. Angiogenesis 24, 251\u2013269 (2021).","journal-title":"Angiogenesis"},{"key":"20917_CR37","doi-asserted-by":"publisher","first-page":"31958","DOI":"10.18632\/oncotarget.24110","volume":"9","author":"N Ai","year":"2018","unstructured":"Ai, N. et al. Ponatinib exerts anti-angiogenic effects in the zebrafish and human umbilical vein endothelial cells via blocking VEGFR signaling pathway. Oncotarget 9, 31958\u201331970 (2018).","journal-title":"Oncotarget"},{"key":"20917_CR38","doi-asserted-by":"publisher","first-page":"5905269","DOI":"10.1155\/2020\/5905269","volume":"2020","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Cabozantinib, a Multityrosine Kinase Inhibitor of MET and VEGF Receptors Which Suppresses Mouse Laser-Induced Choroidal Neovascularization.. J. Ophthalmol. 2020, 5905269 (2020).","journal-title":"J. Ophthalmol."},{"key":"20917_CR39","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41422-019-0229-5","volume":"29","author":"W Zhao","year":"2019","unstructured":"Zhao, W. et al. Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor Inhibition. Cell. Res. 29, 895\u2013910 (2019).","journal-title":"Cell. Res."},{"key":"20917_CR40","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.preteyeres.2021.100969","volume":"85","author":"SM George","year":"2021","unstructured":"George, S. M., Lu, F., Rao, M., Leach, L. L. & Gross, J. M. The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems. Prog Retin Eye Res. 85, 100969 (2021).","journal-title":"Prog Retin Eye Res."},{"key":"20917_CR41","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1158\/2159-8290.CD-22-1441","volume":"13","author":"F Facchinetti","year":"2023","unstructured":"Facchinetti, F. et al. Resistance to selective FGFR inhibitors in FGFR-Driven urothelial cancer. Cancer Discov. 13, 1998\u20132011 (2023).","journal-title":"Cancer Discov"},{"key":"20917_CR42","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cmet.2021.01.011","volume":"33","author":"S Crespo-Garcia","year":"2021","unstructured":"Crespo-Garcia, S. et al. Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL Inhibition. Cell. Metab. 33, 818\u2013832e7 (2021).","journal-title":"Cell. Metab."},{"key":"20917_CR43","doi-asserted-by":"publisher","first-page":"e14611","DOI":"10.7717\/peerj.14611","volume":"11","author":"D Lee","year":"2023","unstructured":"Lee, D. et al. Pemafibrate prevents choroidal neovascularization in a mouse model of neovascular age-related macular degeneration. PeerJ 11, e14611 (2023).","journal-title":"PeerJ"},{"key":"20917_CR44","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10456-013-9398-x","volume":"17","author":"S Rezzola","year":"2014","unstructured":"Rezzola, S. et al. In vitro and ex vivo retina angiogenesis assays. Angiogenesis 17, 429\u2013442 (2014).","journal-title":"Angiogenesis"},{"key":"20917_CR45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-cellbio-100818-125503","volume":"35","author":"N Denans","year":"2019","unstructured":"Denans, N., Baek, S. & Piotrowski, T. Comparing sensory organs to define the path for hair cell regeneration. Annu. Rev. Cell. Dev. Biol. 35, 567\u2013589 (2019).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"20917_CR46","doi-asserted-by":"publisher","first-page":"155050","DOI":"10.1016\/j.phymed.2023.155050","volume":"120","author":"J He","year":"2023","unstructured":"He, J., Zhang, Q., Xia, X. & Yang, L. Lagopsis Supina ameliorates myocardial ischemia injury by regulating angiogenesis, thrombosis, inflammation, and energy metabolism through VEGF, ROS and HMGB1 signaling pathways in rats. Phytomedicine 120, 155050 (2023).","journal-title":"Phytomedicine"},{"key":"20917_CR47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jconrel.2023.10.011","volume":"363","author":"N Park","year":"2023","unstructured":"Park, N., Kim, K. S. & Na, K. Stem cell-derived paracrine factors by modulated reactive oxygen species to enhance cancer immunotherapy. J. Control Release. 363, 670\u2013681 (2023).","journal-title":"J. Control Release"},{"key":"20917_CR48","doi-asserted-by":"publisher","first-page":"108434","DOI":"10.1016\/j.intimp.2021.108434","volume":"103","author":"T Yang","year":"2022","unstructured":"Yang, T. et al. Daphnetin inhibits corneal inflammation and neovascularization on a mouse model of corneal alkali burn. Int. Immunopharmacol. 103, 108434 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"20917_CR49","unstructured":"Caban, M., Owczarek, K., Podsedek, A., Sosnowska, D. & Lewandowska, U. Spent hops extract (Humulus lupulus L.) attenuates inflammation and angiogenesis of the retina via the nuclear factor-kappaB and protein kinase B\/extracellular signal-regulated kinase pathways. J. Physiol. Pharmacol. 74, (2023)."},{"key":"20917_CR50","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/01.CIR.91.3.755","volume":"91","author":"DE Morales","year":"1995","unstructured":"Morales, D. E. et al. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91, 755\u2013763 (1995).","journal-title":"Circulation"},{"key":"20917_CR51","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1016\/j.biomaterials.2014.01.071","volume":"35","author":"B Zhang","year":"2014","unstructured":"Zhang, B. et al. EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma. Biomaterials 35, 4133\u20134145 (2014).","journal-title":"Biomaterials"},{"key":"20917_CR52","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.ijbiomac.2022.09.129","volume":"221","author":"S Vimalraj","year":"2022","unstructured":"Vimalraj, S. A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions. Int. J. Biol. Macromol. 221, 1428\u20131438 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"20917_CR53","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00345-020-03213-z","volume":"39","author":"S Ghafouri","year":"2021","unstructured":"Ghafouri, S. et al. VEGF Inhibition in urothelial cancer: the past, present and future. World J. Urol. 39, 741\u2013749 (2021).","journal-title":"World J. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20917-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20917-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20917-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:02:16Z","timestamp":1761516136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20917-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20917"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20917-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6063109\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study received approval from the relevant ethics committee, and all participants provided informed consent before participating in the research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consented to the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"36890"}}